Group structure
7 companies in 5 countries
Loading your pageโฆ
Loading your pageโฆ
7 companies in 5 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
7 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| HIBICLENS4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** ยท Sponge | Chlorhexidine | United States | Not marketed | 1981 |
| HIBICLENS4% ยท Solution | Chlorhexidine | United States | Marketed | 1976 |
| Hibiscrub, oplossing voor cutaan gebruik 40 mg/mlOplossing voor cutaan gebruik | Chloorhexidinedigluconaat | Netherlands | Authorised | 1984 |
| HIBISTAT0.5% ยท Solution | Chlorhexidine | United States | Marketed | 1980 |
| Hibiwash 40 mg/ml, oplossing voor cutaan gebruikOplossing voor cutaan gebruik | Chloorhexidinedigluconaat | Netherlands | Authorised | 2024 |
| MEVON 77 LIQ - EXTRA MILD.2 % / % ยท Liquid | Triclosan | Canada | Cancelled | 1983 |
| MEVON NO. 72 LIQ1.25 % / % + 1.25 % / % ยท Liquid | Alkyl dimethyl ethylbenzyl ammonium, Benzalkonium | Canada | Cancelled | 1983 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 3 | 3 | 0 | CompaniesAll medicines |
| Canada | 2 | 0 | 2 | CompaniesAll medicines |
| Netherlands | 2 | 2 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Finnish Patent and Registration Office (PRH), Business Information System (YTJ), source query URL, record lastModified (no timezone supplied), retrieval date; CC BY 4.0. Structured extraction/selection by Prognia.
Licence: Creative Commons Attribution (CC BY)
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
State Enterprise Centre of Registers / Valstybฤs ฤฏmonฤ Registrลณ centras; source dataset/resource URL, exact original code/UUID/revision, original CSV ordinal, retrieval time; CC BY 4.0 https://creativecommons.org/licenses/by/4.0/ ; selected field normalization by Prognia.
Licence: Creative Commons Attribution
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.